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Editorial
Oral health in patients with systemic sclerosis
An aspect of secondary importance in the life of the patients?
This editorial refers to The Canadian systemic scler-
osis oral health study: orofacial manifestations and
oral health-related quality of life in systemic sclerosis
compared with the general population, by M. Baron
et al., pages 138694.
Orofacial manifestations due to fibrosis of the skin and
soft tissues are typical in SSc and include amimia, dis-
appearance of cutaneous wrinkles, vertical furrows
around the mouth and sharpening of the nose. Facial
and oral changes also include telangiectasia, sicca syn-
drome, thinning and reduction of mouth width (micro-
cheilia) and opening (microstomia) worsened by
temporo-mandibular joint involvement. Periodontal and
dental abnormalities (decayed, filled and missing teeth)
are also common. Orofacial modifications affect aes-
thetics and are ranked as the most worrying aspects of
SSc [1]. They may alter the patient’s oral health-related
quality of life (OHRQoL), as they hinder eating and cause
difficulty in chewing and speaking. Microstomia also
makes daily hygiene and dental treatment challenging
[2]. Despite their high frequency, oral manifestations and
OHRQoL (measured by questionnaires pertaining to oral
health, capturing functional, social and psychological im-
pacts of oral disease) in SSc patients are underrated and
not comprehensively studied, probably because they are
overshadowed by concomitant, sometimes severe, sys-
temic symptoms.
The article by Baron et al. [3] in this edition of
Rheumatology plugs this gap with a multisite cross-sec-
tional study assessing oral conditions and OHRQoL in a
reasonable number of SSc patients taken from the
Canadian Scleroderma Research Group registry and
compared with age- and sex-matched healthy controls.
An oral examination demonstrated that SSc patients
have significantly more decayed teeth and periodontal
disease, produce less saliva (examined by the Saxon
test) and have a smaller interincisal distance than controls.
SSc patients also show a significantly reduced OHRQoL
compared with controls as assessed by the Oral Health
Impact Profile (OHIP), both in its overall score and in its
seven subscales [3]. Multivariate regression analyses con-
firm SSc as a significant independent predictor of missing
teeth, periodontal disease, interincisal distance, saliva
production and OHIP scores. This high-quality study [3]
confirms the results of previous work that showed a higher
prevalence of dental and periodontal disease in SSc pa-
tients than in controls. However, in contrast to these
studies summarized in the article [3], which do not specify
the professionals who examined the patients, Baron et al.
evaluated 163 SSc patients by standardized examinations
performed by dentists.
Importantly, Baron et al. [3] demonstrated a significantly
worse OHRQoL in SSc than in controls by using the OHIP,
a self-administered questionnaire with excellent measure-
ment properties that is valid and reliable in different popu-
lations and with high sensitivity to change. It is also
potentially useful in both cross-sectional and longitudinal
research in SSc, although it is not disease specific.
However, Baron et al. [3] do not include the Mouth
Handicap in Systemic Sclerosis (MHISS) scale [4], a self-
administered tool created for SSc patients to quantify dis-
ease-specific face and mouth disability. The MHISS
assesses OHRQoL [4] with excellent reliability, construct
validity and good sensitivity to change [5], examining
handicap related to reduced mouth opening and sicca
syndrome as well as aesthetic concerns. In SSc,
OHRQoL evaluated by the MHISS contributes to 36% of
the variance in global disability [4] and is an independent
predictor of health-related quality of life (HRQoL) [6], de-
pression and anxiety [7].
Altogether this evidence demonstrates that oral mani-
festations and impaired OHRQoL, although not life
threatening, are important to SSc patients [1, 2] and
need proper evaluation and treatment. The correlation of
altered OHRQoL with global disability [4] and HRQoL [6]
and mood impairment [7] substantiates the importance of
oral concerns in SSc. The study of Baron et al. [3], al-
though well performed, does not specify HRQoL, disability
and organ involvement. It also does not characterize
whether SSc patients were affected by SS, who, as
described in Alantar et al. [8], report more prominent
oral changes due to salivary gland hypofunctionality.
Baron et al. [3] also use the Saxon text rather than the
method of assessing unstimulated whole salivary flow,
as suggested by the American and European Consensus
Group classification criteria [9]. Moreover, the study does
not classify subjects according to limited or diffuse sub-
sets of SSc, which usually show more severe limitations in
OHRQoL but a lower prevalence of sicca symptoms [6, 7].
As SSc may involve the whole mouth and facial tissues,
a coordinated multidisciplinary approach involving
rheumatologists, dentists, oral hygienists, physiotherap-
ists and other professionals skilled in SSc evaluation
and care is necessary to treat the issues related to oral
problems [8] and OHRQoL [4]. In daily rheumatology
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practice, OHRQoL and oral concerns should be evaluated
by self-assessed questionnaires, which are easy to use
and score and can be both generic (OHIP) and SSc spe-
cific (MHISS), and by measuring mouth opening. These
tools, which are sensitive to change, are also useful to
follow up the efficacy of treatment.
According to recently proposed recommendations [8],
oral problems may be assessed by dentists and oral hy-
gienists, who should take into account the problems of
oral mucosa, involvement of the manducatory apparatus
and mouth (responsible for limitations in mouth opening
that may hinder oral care) and potential treatment-related
adverse events [8]. In terms of imaging, dental panoramic
radiography may detect dental caries early [8], and radi-
ography, echography and eventually MRI may help in
early diagnosis of temporo-mandibular joint involvement
changes involved in microstomia development.
In SSc patients, prevention of mouth infections and
caries includes cessation of tobacco, education and
teaching about oral hygiene, periodontal maintenance
and treatment of sicca concerns with salivary substitutes
and sialagogue drugs. Exercises aimed at maintaining
mouth opening and skin elasticity should be taught
since the earliest phases of the disease to prevent micro-
stomia and to reduce worsening of skin fibrosis [5, 8, 10].
In patients with microstomia, specific mouth-opening re-
habilitation programmes [5, 10], flexible sectional dentures
and splints are recommended [8].
In conclusion, the major merit of Baron et al. [3] is to
confirm on a large population the impairment of oral health
and OHRQoL in SSc and to focus attention on problems
that are not of secondary importance to patients. The re-
sults of the study are a useful starting point for performing
further surveys about OHRQoL in SSc that should include
a better characterization of patients, including evaluation
of secondary SS, disease subsets, global HRQoL, disabil-
ity and organ involvement, and to develop early multidis-
ciplinary interventions for oral health and OHRQoL.
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